 BELLUS Health BLU stock is rocketing higher on Monday and its all thanks to data from a Phase 2b clinical trial of BLU-5937. The post BLU Stock Alert: The Study Data That Has BELLUS Health Blasting Higher Today appeared first on InvestorPlace. 